Literature DB >> 31167784

Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells.

Joshua K Stone1, Jung-Hyun Kim1, Lana Vukadin1, Alexander Richard1, Hannah K Giannini1, Ssang-Taek Steve Lim2, Ming Tan1,2, Eun-Young Erin Ahn3,2.   

Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long noncoding RNA overexpressed in various cancers that promotes cell growth and metastasis. Although hypoxia has been shown to up-regulate MALAT1, only hypoxia-inducible factors (HIFs) have been implicated in activation of the MALAT1 promoter in specific cell types and other molecular mechanisms associated with hypoxia-mediated MALAT1 up-regulation remain largely unknown. Here, we demonstrate that hypoxia induces cancer cell-specific chromatin-chromatin interactions between newly identified enhancer-like cis-regulatory elements present at the MALAT1 locus. We show that hypoxia-mediated up-regulation of MALAT1 as well as its antisense strand TALAM1 occurs in breast cancer cells, but not in nontumorigenic mammary epithelial cells. Our analyses on the MALAT1 genomic locus discovered three novel putative enhancers that are located upstream and downstream of the MALAT1 gene body. We found that parts of these putative enhancers are epigenetically modified to a more open chromatin state under hypoxia in breast cancer cells. Furthermore, our chromosome conformation capture experiment demonstrated that noncancerous cells and breast cancer cells exhibit different interaction profiles under both normoxia and hypoxia, and only breast cancer cells gain specific chromatin interactions under hypoxia. Although the HIF-2α protein can enhance the interaction between the promoter and the putative 3' enhancer, the gain of chromatin interactions associated with other upstream elements, such as putative -7 and -20 kb enhancers, were HIF-independent events. Collectively, our study demonstrates that cancer cell-specific chromatin-chromatin interactions are formed at the MALAT1 locus under hypoxia, implicating a novel mechanism of MALAT1 regulation in cancer.
© 2019 Stone et al.

Entities:  

Keywords:  MALAT1; breast cancer; chromatin structure; histone modification; hypoxia; long noncoding RNA (long ncRNA, lncRNA)

Mesh:

Substances:

Year:  2019        PMID: 31167784      PMCID: PMC6643033          DOI: 10.1074/jbc.RA118.006889

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  A role for the CPF 3'-end processing machinery in RNAP II-dependent gene looping.

Authors:  Athar Ansari; Michael Hampsey
Journal:  Genes Dev       Date:  2005-11-30       Impact factor: 11.361

2.  The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.

Authors:  Qin Yan; Steven Bartz; Mao Mao; Lianjie Li; William G Kaelin
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

3.  H3K4 tri-methylation provides an epigenetic signature of active enhancers.

Authors:  Aleksandra Pekowska; Touati Benoukraf; Joaquin Zacarias-Cabeza; Mohamed Belhocine; Frederic Koch; Hélène Holota; Jean Imbert; Jean-Christophe Andrau; Pierre Ferrier; Salvatore Spicuglia
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

4.  Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase.

Authors:  Xue Zhou; Hong Sun; Haobin Chen; Jiri Zavadil; Thomas Kluz; Adriana Arita; Max Costa
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

5.  Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.

Authors:  Yong Yuan; George Hilliard; Tsuneo Ferguson; David E Millhorn
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

6.  Hypoxia induces a novel signature of chromatin modifications and global repression of transcription.

Authors:  Amber Buescher Johnson; Nicholas Denko; Michelle Craig Barton
Journal:  Mutat Res       Date:  2008-01-16       Impact factor: 2.433

7.  Gene loops juxtapose promoters and terminators in yeast.

Authors:  Justin M O'Sullivan; Sue Mei Tan-Wong; Antonin Morillon; Barbara Lee; Joel Coles; Jane Mellor; Nick J Proudfoot
Journal:  Nat Genet       Date:  2004-08-15       Impact factor: 38.330

Review 8.  Regulation of gene expression by hypoxia.

Authors:  Niall Steven Kenneth; Sonia Rocha
Journal:  Biochem J       Date:  2008-08-15       Impact factor: 3.857

9.  Mediator and cohesin connect gene expression and chromatin architecture.

Authors:  Michael H Kagey; Jamie J Newman; Steve Bilodeau; Ye Zhan; David A Orlando; Nynke L van Berkum; Christopher C Ebmeier; Jesse Goossens; Peter B Rahl; Stuart S Levine; Dylan J Taatjes; Job Dekker; Richard A Young
Journal:  Nature       Date:  2010-08-18       Impact factor: 49.962

10.  Gene expression and hypoxia in breast cancer.

Authors:  Elena Favaro; Simon Lord; Adrian L Harris; Francesca M Buffa
Journal:  Genome Med       Date:  2011-08-26       Impact factor: 11.117

View more
  16 in total

Review 1.  Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.

Authors:  Samaneh Arab; Akram Alizadeh; Samira Asgharzade
Journal:  Clin Exp Med       Date:  2021-01-23       Impact factor: 3.984

2.  LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis.

Authors:  Yuqin Wang; Xiuying Wang; Liwei Han; Dongdong Hu
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

Review 3.  Computational Oncology in the Multi-Omics Era: State of the Art.

Authors:  Guillermo de Anda-Jáuregui; Enrique Hernández-Lemus
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

4.  Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a.

Authors:  Wenzheng Xia; Hanbin Chen; Congying Xie; Meng Hou
Journal:  Aging (Albany NY)       Date:  2020-05-08       Impact factor: 5.682

Review 5.  Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications.

Authors:  Qi-Yuan Huang; Guo-Feng Liu; Xian-Ling Qian; Li-Bo Tang; Qing-Yun Huang; Li-Xia Xiong
Journal:  Cancers (Basel)       Date:  2019-11-16       Impact factor: 6.639

6.  Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.

Authors:  Suyan Tian; Mingbo Tang; Jialin Li; Chi Wang; Wei Liu
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

Review 7.  Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy.

Authors:  Rama Rao Malla; Batoul Farran; Ganji Purnachandra Nagaraju
Journal:  World J Biol Chem       Date:  2021-03-27

Review 8.  Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.

Authors:  Antonietta Rosella Farina; Lucia Cappabianca; Michela Sebastiano; Veronica Zelli; Stefano Guadagni; Andrew Reay Mackay
Journal:  J Exp Clin Cancer Res       Date:  2020-06-15

9.  lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma.

Authors:  Lei Xiao; Weiping Wang; Jingjing Zhao; Hongyan Xu; Shaozhen Li; Xiuhua Yang
Journal:  Oncol Lett       Date:  2020-08-26       Impact factor: 2.967

10.  The Effect of Genomic DNA Contamination on the Detection of Circulating Long Non-Coding RNAs: The Paradigm of MALAT1.

Authors:  Athina N Markou; Stavroula Smilkou; Emilia Tsaroucha; Evi Lianidou
Journal:  Diagnostics (Basel)       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.